IDEAYA Biosciences (IDYA) Other financing activities (2018 - 2026)
IDEAYA Biosciences (IDYA) posted Other financing activities of $1.2 million for Q1 2026, up 373.56% sequentially from -$435000.0 in Q4 2025, and up 4.94% YoY from $1.1 million in Q1 2025.
IDEAYA Biosciences (IDYA) Other financing activities (2018 - 2026) Analysis & Trends
IDEAYA Biosciences has reported Other financing activities for 9 years, with the latest figure at $1.2 million in Q1 2026.
- Quarterly Other financing activities rose 4.94% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 153.64% YoY) and the FY2025 annual result came in at $1.5 million, up 3.75% from the prior year.
- Other financing activities climbed to $1.2 million in Q1 2026 per IDYA's latest filing, from -$435000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $5.5 million in Q1 2024 and troughed at -$8.0 million in Q4 2024.
- A 5-year average of $423937.5 and a median of $619000.0 in 2022 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 1392.08% in 2024, down 1482.12% in 2024.
- Over 5 years, Other financing activities stood at $1.0 million in 2022, then slumped by 43.14% to $576000.0 in 2023, then plunged by 1482.12% to -$8.0 million in 2024, then surged by 94.54% to -$435000.0 in 2025, then soared by 373.56% to $1.2 million in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $1.2 million, -$435000.0, and $384000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | IDEAYA Biosciences | 3.50 Bn | 2.67 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 139.81 Mn |
| Jun 30, 2026 | 139.81 Mn |
| Mar 31, 2026 | 1.19 Mn |
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | -435,000.00 |
| Dec 31, 2025 | -435,000.00 |
| Sep 30, 2025 | 384,000.00 |
| Sep 30, 2025 | 384,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Mar 31, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.13 Mn |
| Dec 31, 2024 | -7.96 Mn |
| Dec 31, 2024 | -7.96 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Mar 31, 2024 | 5.46 Mn |
| Mar 31, 2024 | 5.46 Mn |